Labshake search
Citations for Tocris :
1 - 50 of 342 citations for PI 3 Kinase p110 delta Rabbit Recombinant mAb since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2023Quote: ... P110 (1 μM, Tocris, Cat. No. 6897), BAPTA-AM (10mM Tocris ...
-
bioRxiv - Bioengineering 2023Quote: ... or phosphoinositide 3-kinase (PI3K) (LY 294002, 10 µM, Tocris, UK) for 4 days ...
-
bioRxiv - Neuroscience 2022Quote: Dynamin-related protein 1 (Drp1) – mitochondria fission 1 protein (Fis1) peptide inhibitor P110 was purchased from Tocris Bioscience (cat ...
-
bioRxiv - Cell Biology 2020Quote: ... Rho-kinase inhibitor (Tocris) was added to single cell dissociated organoids ...
-
bioRxiv - Neuroscience 2021Quote: ... namely the mitogen activated protein kinase kinase (MAPKK) inhibitor U0126 (50 μM) and the CaM kinase II (CaMKII) inhibitor KN-62 (10 μM) (Tocris Bioscience, United Kingdom). The inhibitors were added to the cultures thirty minutes prior to DOI treatment ...
-
bioRxiv - Developmental Biology 2021Quote: ... and PI-103 (50 nM; Tocris), which was added for 24 hours ...
-
bioRxiv - Developmental Biology 2021Quote: ... and PI-103 (50 nM; Tocris), which was added for 24 hours ...
-
bioRxiv - Evolutionary Biology 2020Quote: ... and PI-103 (50 nM, Tocris, 2930) in CDM2 to specify APS ...
-
bioRxiv - Molecular Biology 2023Quote: ... and 50 nM PI 103 (Tocris, 2930) and incubated for 24hrs ...
-
bioRxiv - Neuroscience 2022Quote: ... 12-well plates at 3-4 × 105 cells/well in mTeSR1 with 10 µM rho-kinase inhibitor (Y-27632; Tocris, 1254). Medium without the inhibitor was replaced daily until the cells reach 80-100% confluency ...
-
bioRxiv - Pharmacology and Toxicology 2022Quote: Kinase inhibitors were purchased from Tocris (www.tocris.com), Selleck Chemicals (www.selleckchem.com) ...
-
bioRxiv - Cell Biology 2022Quote: The mitogen-activated protein kinase kinase 1/2 (MEK1/2) inhibitor U0126 and the p38 MAPK inhibitor SB203580 were purchased from Tocris Bioscience (Bristol ...
-
bioRxiv - Bioengineering 2022Quote: ... 50 nM PI-103 (Tocris Bioscience, catalogue no. 2930) and 100 ng/ml activin A (Peprotech ...
-
bioRxiv - Immunology 2019Quote: ... inhibitor of PI3-Kinase (Wortmanin, 100 nM, Tocris), inhibitor of p38 MAP kinase (SB203580 ...
-
bioRxiv - Immunology 2019Quote: ... inhibitor of p38 MAP kinase (SB203580, 10 μM, Tocris), inhibitor of ERK MAP kinase (PD90859 ...
-
bioRxiv - Immunology 2019Quote: ... inhibitor of ERK MAP kinase (PD90859, 10 μM, Tocris), inhibitor of Cdc42 (ML141 ...
-
bioRxiv - Genetics 2023Quote: ... 10μM Y-27632 Rho-kinase inhibitor (ROCKi; Tocris #1254) was added to culture media ...
-
bioRxiv - Cell Biology 2022Quote: ... 1.5 mM Na3VO4 and 1 µM PI-PLC inhibitor U73122 (Tocris) were added to the homogenization buffer ...
-
bioRxiv - Developmental Biology 2020Quote: ... and 10 μM ALK4/5/7 kinase inhibitor SB431542 (Tocris) at 37 °C in 5% CO2 ...
-
bioRxiv - Cell Biology 2022Quote: ... Stocks of the kinase inhibitor MLi-2 (10 mM; Tocris) were stored in DMSO at −20°C.
-
bioRxiv - Neuroscience 2021Quote: ... coiled-coil containing protein kinase (ROCK1/2) Y27632 (Tocris, Inc.) at 10 µM in PBS for 1-2 hr ...
-
bioRxiv - Cancer Biology 2022Quote: ... 25 μM ML-7 (Tocris, myosin light-chain kinase inhibitor), 500 μM carbenoxolone (Sigma ...
-
bioRxiv - Neuroscience 2022Quote: ... and 10μM Y-27632 dihydrochloride (Rho kinase ROCK inhibitor) (Tocris) from day 20 for the whole duration of terminal differentiation ...
-
bioRxiv - Biophysics 2023Quote: Stocks of the kinase inhibitors MLi-2 (10 mM; Tocris) and GZD-824 (10 mM ...
-
bioRxiv - Neuroscience 2024Quote: ... and 10μM Y-27632 dihydrochloride (Rho kinase ROCK inhibitor) (Tocris) from day 20 for the whole duration of terminal differentiation ...
-
bioRxiv - Bioengineering 2024Quote: ... 10 μM Rho kinase inhibitor (RI, Y-27632) (Tocris, 1254) was used ...
-
bioRxiv - Developmental Biology 2022Quote: ... Media containing Src-kinase inhibitor (10μM PP2; Tocris Bioscience; Cat #1407) and/or FGF8b (100ng/ml ...
-
bioRxiv - Bioengineering 2021Quote: ... supplemented with Rho Kinase Inhibitor (Y-27632, 10 µM, Tocris, 1254) (Day 0) ...
-
bioRxiv - Bioengineering 2022Quote: ... supplemented with Rho Kinase Inhibitor (Y-27632, 10 µM, Tocris, 1254) (day 0) ...
-
bioRxiv - Bioengineering 2023Quote: ... Rho-associated protein kinase (ROCK) (Y-27632, 25 µM, Tocris, UK), or phosphoinositide 3-kinase (PI3K ...
-
bioRxiv - Neuroscience 2022Quote: Pharmacological compounds were obtained from the following sources: Rho Kinase Inhibitor (Tocris). Retinoic Acid (Sigma) ...
-
bioRxiv - Developmental Biology 2022Quote: ... 10 μM Rho-associated protein kinase (ROCK) inhibitor Y-27632 (Tocris, 1254) was added to the culture medium for 24 hours.
-
bioRxiv - Developmental Biology 2021Quote: ... 7 μg/ml human recombinant Insulin (Tocris), 100 ng/ml recombinant human/mouse FGF8b (Tocris ...
-
bioRxiv - Developmental Biology 2021Quote: ... 100 ng/ml recombinant human/mouse FGF8b (Tocris) between days 1-11 (range tested ...
-
bioRxiv - Microbiology 2019Quote: ... and incubated with recombinant protein (GenScript, Sigma, Tocris) of each analyte for 4 h at room temperature ...
-
bioRxiv - Neuroscience 2019Quote: The brain penetrant and orally bioavailable p21-activated kinase (PAK) inhibitor FRAX486 (Tocris, 5190) was used to inhibit PAK1-4 in pharmacological inhibition/rescue experiments ...
-
bioRxiv - Neuroscience 2021Quote: We inhibited LRRK2 kinase activity with the selective LRRK2 inhibitor MLi-2 (Tocris 5756). MLi-2 has low solubility in water ...
-
bioRxiv - Cancer Biology 2023Quote: ... a selection p38 MAP kinase inhibitor and 10 nM nicotinamide (Tocris Bioscience, Bristol, UK) for the first day of passaging to prevent anoikis ...
-
bioRxiv - Cell Biology 2023Quote: ... The medium was supplemented with 10 μM Rho kinase (ROCK) inhibitor Y-27632 (ROCKi, Tocris) for the first 24 h after passaging.
-
bioRxiv - Genetics 2023Quote: ... When thawing KOLF2.1Js 10 µM Rho-associated protein kinase (ROCK) inhibitor (Y-27632) (Tocris, #1254) was added into the culture media overnight.
-
bioRxiv - Bioengineering 2023Quote: ... or pharmacological inhibitors of focal adhesion kinase (FAK) (FAK inhibitor 14, 5 µM, Tocris, UK), Rho-associated protein kinase (ROCK ...
-
bioRxiv - Developmental Biology 2024Quote: ... The medium was supplemented with Rho-associated protein kinase (ROCK) inhibitor Y-27632(Tocris, 1254) at a final concentration of 10 µM for the first 24h after passaging ...
-
bioRxiv - Molecular Biology 2022Quote: ... cells were plated in StemFlex media supplemented with 10uM Y-27632 rho kinase inhibitor (Tocris, 1254). Genomic DNA extraction was performed 72 hours after transfection ...
-
bioRxiv - Pharmacology and Toxicology 2023Quote: ... [2-Amino-4-[3-(trifluoromethyl)phenyl]-3-thienyl] phenylmethanone (VCP 171; Tocris, 1018830-99-3), 5-[2-(5-nitro-2-furanyl)ethenyl]-2-furancarboxylic acid ...
-
bioRxiv - Cell Biology 2024Quote: ... bEnd.3 cells were treated with either 3-methyladenine (3-MA, #1292 Tocris, MN, USA) or rapamycin (Rapa ...
-
bioRxiv - Cell Biology 2021Quote: H9 hESCs were treated with 10 µM Rho-associated protein kinase inhibitor (ROCKi, Tocris Bioscience #Y-27632) for 24 h before they were dissociated to single cells and pelleted ...
-
bioRxiv - Cell Biology 2020Quote: ... The Src-family kinases inhibitor PP2 and Syk inhibitor PRT-060318 were purchased from TOCRIS (Abingdon, UK) and Caltag Medsystems (Buckingham ...
-
bioRxiv - Physiology 2022Quote: Tissue was homogenized in 1X PBS and 200 nM adenosine kinase inhibitor ABT 702 dihydrochloride (Tocris Bioscience) at a concentration of 100 mg tissue/ 1 mL PBS ...
-
bioRxiv - Bioengineering 2024Quote: ... and cultured using mTESRTM Plus medium supplemented with 10 µM Y27632 Rho-kinase (ROCK) inhibitor (Tocris; 1254). After 24 hours of culture ...
-
bioRxiv - Bioengineering 2024Quote: ... and cultured using mTESRTM Plus medium supplemented with 10 µM Y27632 Rho-kinase (ROCK) inhibitor (Tocris; 1254). After 24 hours of culture ...